Clinical impact of genotype 1 TT virus infection in patients with chronic hepatitis C and response of TT virus to α-interferon

Journal of Gastroenterology and Hepatology (Australia)

Volumn 15, Issue 11, 2000, Pages 1292-1297

  Nishizawa, Yoshio ^a   Tanaka, Eiji ^a   Orii, Koji ^a   Rokuhara, Akinori ^a   Ichijo, Tetsuya ^a   Yoshizawa, Kaname ^a   Kiyosawa, Kendo ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic hepatitis; Genotype; Hepatitis C virus; Interferon; TT virus

Indexed keywords

ALPHA INTERFERON; RECOMBINANT ALPHA INTERFERON;

ADULT; ARTICLE; CLINICAL FEATURE; DISEASE ACTIVITY; DRUG EFFICACY; FEMALE; GENOTYPE; HEPATITIS C; HUMAN; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SUPERINFECTION; TORQUE TENO VIRUS; VIRUS LOAD;

EID: 0033674174     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2000.02342.x     Document Type: Article

References (27)

1. A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology
2. Molecular cloning and characterization of a novel DNA virus (TTV) associated with post-transfusion hepatitis of unknown etiology
3. Molecular and biophysical characterization of TT virus: Evidence for a new virus family infecting humans
4. Marked genomic heterogeneity and frequent mixed infection of TT virus demonstrated by PCR with primers from coding and noncoding regions
5. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis
6. Significance of antibody to hepatitis C virus in Japanese patients with viral hepatitis: Relationship between anti-HCV antibody and the prognosis of non-A, non-B post-transfusion hepatitis
7. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus
8. Effect of interferon administration on serum hepatitis C virus RNA in patients with chronic hepatitis C
9. Viral and host factors that contribute to the efficacy of interferon-alpha 2a therapy in patients with chronic hepatitis C
10. Prevalence and disease association of TT virus infection in Japanese patients with viral hepatitis
11. Transfusion-associated TT Virus infection and its relationship to liver disease
12. Presence of a newly described human DNA virus (TTV) in patients with liver disease
13. Infection with an unenveloped DNA virus (TTV) in patients with acute or chronic liver disease of unknown etiology and in those positive for hepatitis C virus RNA
14. Susceptibility of TT virus to infection therapy
15. Detection of TTV DNA in serum of patients with chronic liver disease and interferon efficacy
16. The role of TT virus infection in acute viral hepatitis
17. High prevalence of TT virus infection in healthy children and adults and in patients with liver disease in Taiwan
18. TT virus infection in patients with chronic hepatitis B or C. Influence on clinical, histological and virological features
19. Classification of chronic hepatitis: Diagnosis, grading and staging
20. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: Application to clinical surveys and tracing infectious sources
21. A proposed system for the nomenclature of hepatitis C viral genotypes
22. Very high prevalence of TT virus (TTV) infection in general population of Japan revealed by a new set of PCR primers
23. Avoiding false positives with PCR
24. Real time quantitative PCR
25. Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma
26. Clinical and virological profiles in patients with multiple hepatitis virus infections
27. TT virus infection in an area of high endemicity for hepatitis C